Deals

Pfizer buys Biohaven for $11.6 billion

The deal should put an end to the protracted M&A lull in the biotech sector. Piper Sandler analyst Christopher Raymond also thinks so. He believes that the Pfizer deal could restore sentiment about mergers and biotechnology in general.

The U.S. biotech sector experienced its worst April since 2002. COVID-19 is becoming a major cause. Omicron is not such a dangerous strain, and demand for vaccines is falling due to more and more people being fully vaccinated.

Bank of America has no plans to offer crypto services

BofA CEO Moynihan said that the company will not offer services related to cryptocurrency in the near future. However, he acknowledged the importance of digital payments in today's economy. According to Moynihan, the main obstacle to the crypto industry is regulatory problems. The SEC is suspicious of companies offering cryptocurrency

Major Cryptocurrency Exchanges Return 3,000 BTC Valued at $172 Million to German Government

In a significant financial move, the German government recently received 3,000 bitcoins (BTC) from major cryptocurrency exchanges. This transaction was facilitated by well-known platforms such as Kraken, Coinbase, and Bitstamp, according to a report by Arkham Intelligence. At the time of the transaction, these assets were valued at approximately

SEC Files Lawsuit Against Silvergate Bank for Alleged Reporting Violations and Mismanagement

The United States Securities and Exchange Commission (SEC) has initiated legal action against Silvergate Bank and several of its top executives. This move stems from accusations that the bank failed to comply with certain regulatory requirements, including reporting obligations, internal accounting controls, and the proper maintenance of financial records. The

Read next